Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Yeh

Interventional Cardiology Boston, MA Medical Doctor

NPI 1154302057 CMS profile 6421

185 Pilgrim Road, Beth Israel Deaconess Medical Center, Baker 4, Boston, MA 02215

Open in the dashboard

General payments

$412,038

369 records reported · program years 2019–2025

Research payments

$23,500

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,650,914 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Robert Yeh of Boston, MA is reported in the CMS Open Payments database as having received $412,038 across 369 general payments and $23,500 in research payments paid to them. Separately, studies naming them as principal investigator received $1,650,914 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $56,866 56
2024 General $82,413 98
2023 General $61,084 72
2023 Research $3,250 1
2022 General $63,609 41
2022 Research $4,250 1
2021 General $42,017 19
2021 Research $16,000 2
2020 General $32,690 23
2019 General $73,359 60

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Yeh
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Robert Yeh were reported at $56,866. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Robert Yeh Interventional Cardiology median Middle half National median
2019 $73,359 $1,097 $329–$3,048 $163
2020 $32,690 $473 $161–$1,480 $114
2021 $42,017 $677 $233–$1,827 $132
2022 $63,609 $978 $333–$2,724 $149
2023 $61,084 $1,136 $382–$2,986 $160
2024 $82,413 $1,181 $395–$3,326 $164
2025 $56,866 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $121,495 115 payments
  2. Medtronic, Inc. $95,335 107 payments
  3. Shockwave Medical, Inc $55,782 32 payments
  4. Abbott Laboratories $39,261 34 payments
  5. CathWorks, Inc. $31,229 17 payments
  6. Medtronic Vascular, Inc. $27,947 26 payments
  7. CSL Behring $18,000 6 payments
  8. Magenta Medical Inc $8,831 3 payments
  9. Edwards Lifesciences Corporation $4,986 3 payments
  10. ZOLL Circulation Inc $4,250 2 payments
  11. Other $4,921 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $267,360 100 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $84,019 54 payments
  3. Travel and Lodging $25,403 90 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $23,250 9 payments
  5. Food and Beverage $9,628 113 payments
  6. Grant $2,379 3 payments
Products named General payments · program years 2019–2025
  1. Xience V coronary stent system $32,726 13 payments
  2. FFRangio $31,229 17 payments
  3. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $23,808 12 payments
  4. RESOLUTE ONYX $19,209 21 payments
  5. Vascular Lithotripsy $18,461 6 payments
  6. Resolute $15,228 20 payments
  7. ONYX FRONTIER $15,221 10 payments
  8. General - Therapies $12,319 13 payments
  9. IN.PACT Admiral $11,625 4 payments
  10. SYMPLICITY G3 $11,075 2 payments
  11. Other $111,896 118 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. ZOLL Circulation Inc $23,500 4 payments

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$66,440

Medicare's payments for the services billed

Medicare patients

283

Average age 76

Services billed

609

125 women, 158 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 69%
Heart failure 55%
Arthritis 51%
Atrial fibrillation 48%
Chronic kidney disease 46%
Diabetes 41%
Depression 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

373 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record